{"gene":"GRPR","run_date":"2026-04-28T18:06:53","timeline":{"discoveries":[{"year":2011,"finding":"MOR1D heterodimerizes with GRPR in the spinal cord, and morphine triggers co-internalization of both MOR1D and GRPR, whereas GRP specifically triggers only GRPR internalization. This heterodimerization mediates opioid-induced itch via unidirectional cross-activation of GRPR signaling by MOR1D, downstream through PLCβ3 and IP3R3.","method":"Co-immunoprecipitation, receptor internalization assays, genetic and pharmacologic inhibition of PLCβ3/IP3R3, behavioral assays in knockout mice","journal":"Cell","confidence":"High","confidence_rationale":"Tier 2 — reciprocal Co-IP, multiple orthogonal methods (internalization, pharmacologic blockade, KO mice), replicated in behavioral and biochemical contexts","pmids":["22000021"],"is_preprint":false},{"year":2014,"finding":"5-HT1A and GRPR form receptor heteromeric complexes in spinal cord neurons; co-activation of 5-HT1A and GRPR greatly potentiates subthreshold GRP-induced Ca2+ transients and action potential firing in GRPR+ neurons, establishing a descending serotonergic facilitation of GRP-GRPR itch signaling.","method":"Immunostaining, biochemical co-localization, biophysical/FRET studies, calcium imaging, pharmacological and behavioral screening","journal":"Neuron","confidence":"High","confidence_rationale":"Tier 2 — multiple orthogonal methods including biochemical interaction, calcium imaging, electrophysiology, and behavioral assays in one study","pmids":["25453842"],"is_preprint":false},{"year":2014,"finding":"Pharmacological and genetic blockade of GRP-GRPR signaling does not significantly affect intrathecal BNP-induced scratching, demonstrating that BNP-NPRA signaling does not function upstream of the GRP-GRPR dedicated neuronal pathway for itch.","method":"Pharmacological blockade, genetic knockout, intrathecal injection behavioral assays, in situ hybridization, RT-PCR","journal":"Molecular pain","confidence":"Medium","confidence_rationale":"Tier 2 — genetic and pharmacologic epistasis with behavioral readout, single lab study","pmids":["24438367"],"is_preprint":false},{"year":2014,"finding":"GRPR and NMBR cross-inhibit each other's signaling; in double-knockout mice lacking both Nmbr and Grpr, histaminergic itch is significantly reduced, demonstrating that GRPR and NMBR compensate for each other to maintain normal histamine-evoked itch. GRPR activity is enhanced in Nmbr KO mice and vice versa. GRP can signal through both GRPR and NMBR, while GRPR+ neurons act downstream of NMBR+ neurons in histaminergic itch circuits.","method":"Double knockout mice, single knockout mice behavioral assays, pharmacological scratching assays, GRPR expression analysis","journal":"The Journal of neuroscience","confidence":"High","confidence_rationale":"Tier 2 — genetic epistasis with double KO and multiple behavioral readouts, replicated across multiple itch modalities","pmids":["25209280"],"is_preprint":false},{"year":2011,"finding":"GRPR mediates GRP-induced neutrophil chemotaxis; GRP-induced neutrophil migration in vitro is dependent on PLC-β2, PI3K, ERK, and p38 signaling, and is independent of Gαi protein. In vivo, GRP-induced peritoneal neutrophil recruitment is blocked by the GRPR antagonist RC-3095 and requires macrophages and TNF.","method":"In vivo peritoneal neutrophil recruitment assay, in vitro chemotaxis assay with pharmacological inhibitors, macrophage depletion, TNF neutralization","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 2 — multiple pharmacological inhibitors defining signaling pathway, in vivo and in vitro, genetic/pharmacologic blockade of GRPR","pmids":["22203955"],"is_preprint":false},{"year":2015,"finding":"GRPR signals through the PI3Kγ/Akt pathway in spinal cord neurons; GRP directly activates small-size capsaicin-sensitive DRG neurons causing Ca2+ transients and membrane depolarization (~20 mV), and GRPR activation induces Akt phosphorylation in ex vivo spinal cords and in GRPR-transfected HEK293 cells. PI3Kγ inhibition reduces GRP-induced scratching.","method":"Electrophysiology (patch clamp), calcium imaging, Akt phosphorylation assay in ex vivo spinal cord and transfected HEK293 cells, intrathecal pharmacology, behavioral assays","journal":"The Journal of neuroscience","confidence":"High","confidence_rationale":"Tier 1-2 — reconstitution in transfected cells, ex vivo electrophysiology, multiple orthogonal methods, behavioral validation","pmids":["26658875"],"is_preprint":false},{"year":2019,"finding":"Spinal GRPR+ neurons (excitatory interneurons) receive direct and indirect inputs from C and Aδ fibers and form contacts with NK1R-expressing projection neurons. Noxious or cooling agents inhibit GRPR neuron activity via GABAergic signaling; capsaicin enhances both excitatory and inhibitory spontaneous synaptic transmission onto GRPR neurons.","method":"Electrophysiology, immunohistochemistry, pharmacological manipulation (GABAergic), behavioral assays","journal":"Scientific reports","confidence":"High","confidence_rationale":"Tier 2 — electrophysiology with pharmacological dissection and circuit mapping, multiple methods","pmids":["31676846"],"is_preprint":false},{"year":2019,"finding":"Spinal galanin+ GABAergic neurons form inhibitory synapses with GRPR+ neurons and gate GRPR+-dependent itch signaling; spinal nNOS+ neurons also provide local inhibitory input to GRPR+ neurons; GRPR+ neurons additionally receive long-range inhibitory input from the rostral ventromedial medulla.","method":"Viral tracing, electrophysiology, immunohistochemistry, circuit dissection","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 2 — viral circuit tracing combined with electrophysiology and functional behavioral validation","pmids":["31806757"],"is_preprint":false},{"year":2004,"finding":"Key amino acids in GRPR responsible for high-affinity GRP binding were identified; residues K101, Q121, A198, P199, S293, R288, and T297 are critical for GRP selectivity. Single and combined mutations in these residues reduce GRP affinity, and reverse mutations in BRS-3 confer GRP affinity gain.","method":"Site-directed mutagenesis, radioligand binding assays, chimeric receptor analysis, molecular modeling","journal":"Biochemical pharmacology","confidence":"High","confidence_rationale":"Tier 1 — mutagenesis with binding assays and reverse-mutation confirmation, multiple mutations tested","pmids":["15670577"],"is_preprint":false},{"year":2013,"finding":"GRP acts via postsynaptic BB2 (GRPR) receptors in rat paraventricular thalamic neurons to suppress a Ba2+-sensitive inward rectifier K+ conductance and activate a non-selective cation conductance with TRPV1-like biophysical and pharmacological properties, producing sustained membrane depolarization and burst/tonic firing.","method":"Perforated patch clamp electrophysiology in acute brain slices, pharmacological dissection with TRPV1 antagonists and BB2 antagonists","journal":"The Journal of physiology","confidence":"High","confidence_rationale":"Tier 1 — direct electrophysiological recording with pharmacological dissection in acute slices, multiple ionic conductances identified","pmids":["23359674"],"is_preprint":false},{"year":2005,"finding":"Brain GRPR (BB2 receptor)-mediated activation of sympatho-adrenomedullary outflow (plasma catecholamine release) in rats involves the PLC/diacylglycerol lipase signaling pathway rather than PLA2; GRP and bombesin (but not neuromedin B) elevate plasma catecholamines via BB2 receptors, and this is blocked by PLC and diacylglycerol lipase inhibitors.","method":"Intracerebroventricular injection, pharmacological inhibition of PLC/diacylglycerol lipase vs PLA2, plasma catecholamine measurement, receptor-subtype-selective antagonists","journal":"European journal of pharmacology","confidence":"Medium","confidence_rationale":"Tier 2 — pharmacological dissection of signaling pathway in vivo with receptor-selective antagonists, single lab","pmids":["15910801"],"is_preprint":false},{"year":2016,"finding":"GRPR activation by bombesin (BBN) in prostate cancer cells promotes epithelial-to-mesenchymal transition (EMT), upregulating TWIST, SNAIL, and SLUG mRNA while downregulating E-cadherin and β-catenin. GRPR activation also increases tumor cell proliferation, migration in vitro, and tumor growth and invasion in vivo; blockade of GRPR upregulates E-cadherin and downregulates VIMENTIN and SNAIL.","method":"Stable GRPr transfection in Ace-1 cells, proliferation assay, migration assay, bioluminescence tumor growth imaging, qRT-PCR for EMT markers, in vivo xenograft","journal":"The Prostate","confidence":"Medium","confidence_rationale":"Tier 2 — defined cellular phenotype with gain-of-function and loss-of-function, multiple readouts, in vitro and in vivo","pmids":["26939805"],"is_preprint":false},{"year":2023,"finding":"GRP/GRPR signaling enhances alcohol-associated liver injury through two distinct mechanisms: IRF1-mediated Caspase-1 inflammasome activation and NOX2-dependent reactive oxygen species production. GRPR interacts with TLR4 to activate STAT1, which binds promoters of MLKL and CCL2 to induce TEC necroptosis, necroinflammation, and macrophage recruitment in acute kidney injury; STAT1 also induces GRP synthesis forming a positive feedback loop.","method":"Grpr knockout mice (global and conditional), GRPR overexpression, ChIP (STAT1 binding), co-immunoprecipitation (GRPR-TLR4 interaction), STAT1 overexpression rescue, pharmacological antagonist (RH-1402)","journal":"Hepatology / Molecular therapy","confidence":"High","confidence_rationale":"Tier 1-2 — genetic knockout, conditional KO in tubular cells, mechanistic rescue with STAT1 overexpression, Co-IP for protein interaction, and pharmacological validation","pmids":["37409771","37415332"],"is_preprint":false},{"year":2020,"finding":"GRPR and NPRA (natriuretic peptide receptor A) signaling activate ERK1/2 in spinal neurons as a critical downstream pathway for itch transmission; phosphorylated ERK is detected in interneurons expressing GRPR, NPRA, NMBR, and sst2A. Blocking GRPR by genetic approaches or toxins significantly attenuates spinal ERK phosphorylation.","method":"RNA sequencing, western blot for phospho-ERK, pharmacological/genetic GRPR blockade, HEK293T transfection with receptor agonist stimulation, chronic itch mouse models","journal":"The Journal of investigative dermatology","confidence":"Medium","confidence_rationale":"Tier 2 — genetic and pharmacological GRPR blockade with ERK phosphorylation readout, supported by cell-based reconstitution","pmids":["33039402"],"is_preprint":false},{"year":2000,"finding":"GRP-R-deficient male mice display increased non-aggressive social responses and altered olfactory preference (preferring conspecific odors over their own), establishing a role for GRPR in modulating social investigatory behavior and conspecific odor cognition.","method":"Germline knockout mice, social interaction behavioral tests, olfactory preference tests, pharmacological (diazepam) controls","journal":"Brain research","confidence":"Medium","confidence_rationale":"Tier 2 — clean KO with defined behavioral phenotype, multiple behavioral paradigms, single lab","pmids":["10869497"],"is_preprint":false},{"year":2006,"finding":"GRP-R immunoreactivity localizes to the plasma membrane of tumor cells, and receptor immunostaining undergoes translocation after bombesin (BN) exposure, confirming receptor internalization upon agonist binding.","method":"Antipeptide antibody development, Western blot, immunohistochemistry, transfected cell surface staining, ligand-induced internalization/translocation assay","journal":"Virchows Archiv","confidence":"Medium","confidence_rationale":"Tier 3 — antibody-based localization with internalization validation in transfected cells, single lab","pmids":["16967266"],"is_preprint":false},{"year":2023,"finding":"GRP/GRPR promotes hyperuricemia-induced tubular injury by suppressing ABCG2/PDZK1 and increasing TGF-β/Smad3 via NF-κB pathway activation; GRPR knockout or conditional knockout in renal tubular epithelial cells protects against hyperuricemia-induced renal fibrosis and inflammation.","method":"GRPR knockout and conditional KO mice, RNA-seq, NF-κB inhibitor, GRPR overexpression in HK2 cells, GRPR antagonist RH-1402 treatment in vivo","journal":"Biochemical pharmacology","confidence":"Medium","confidence_rationale":"Tier 2 — genetic KO with mechanistic pathway identification by RNA-seq and pharmacological inhibition, single lab","pmids":["38084678"],"is_preprint":false},{"year":2023,"finding":"Spinal microglia activate the NLRP3/caspase-1/IL-1β axis under chronic itch conditions, and IL-1β signals through IL-1R1 expressed on GRPR+ neurons to enhance their activation, establishing a microglia-GRPR+ neuron interaction axis in chronic itch.","method":"NLRP3/caspase-1 pharmacological blockade, Grpr-eGFP and Grpr KO mice, intrathecal IL-1β and IL-1R1 antagonist injection, RNAscope ISH, immunohistochemistry","journal":"Allergy","confidence":"Medium","confidence_rationale":"Tier 2 — genetic Grpr KO, pharmacological manipulation, and receptor-specific interventions with behavioral readout, single lab","pmids":["36876522"],"is_preprint":false},{"year":2022,"finding":"GRPR+ neurons in the superficial dorsal horn are glutamatergic vertical cells concentrated in lamina I and outer lamina II; they receive monosynaptic input from Trpv1-expressing nociceptive afferents, respond to both noxious and pruritic stimuli, and their axons target projection neuron-containing regions. Chemogenetic activation produces both pain-related and itch-related behaviors.","method":"GRPR CreERT2 mouse line, viral tracing, immunohistochemistry, electrophysiology, DREADD-based chemogenetics, behavioral assays","journal":"Pain","confidence":"High","confidence_rationale":"Tier 2 — genetic cell-type identification, circuit tracing, electrophysiology, and chemogenetic functional validation with multiple behavioral readouts","pmids":["35543635"],"is_preprint":false},{"year":1995,"finding":"GRPR was mapped to the Xp22.1-p22.2 region of the human X chromosome, localized between DXS43 and CALB3, establishing its chromosomal position.","method":"YAC contig construction, STS mapping, restriction mapping","journal":"Genomics","confidence":"Medium","confidence_rationale":"Tier 2 — direct physical mapping by YAC contig with multiple STSs, replicated by comparative mouse mapping","pmids":["7759104"],"is_preprint":false}],"current_model":"GRPR is a G protein-coupled receptor that, upon binding GRP, activates downstream signaling through PLC/IP3, PI3Kγ/Akt, and MAPK/ERK pathways to regulate itch transmission in spinal GRPR+ glutamatergic interneurons, neutrophil chemotaxis, cancer cell proliferation/EMT, and organ inflammation; it can heterodimerize with MOR1D to mediate opioid-induced itch via cross-activation, and with 5-HT1A to potentiate itch signaling, while its neuronal activity is gated by local GABAergic and long-range inhibitory inputs, and its ligand-binding specificity is determined by key extracellular/transmembrane residues including K101, Q121, A198, P199, S293, R288, and T297."},"narrative":{"teleology":[{"year":1995,"claim":"Establishing the chromosomal locus of GRPR at Xp22.1-p22.2 provided the foundation for genetic studies of this receptor in humans.","evidence":"YAC contig construction and STS mapping on human X chromosome","pmids":["7759104"],"confidence":"Medium","gaps":["No functional consequence of X-linkage explored","No disease-associated variants identified at this locus"]},{"year":2000,"claim":"Germline Grpr knockout revealed a behavioral role in social interaction and olfactory processing, demonstrating CNS functions beyond gut/cancer biology.","evidence":"Grpr KO mice tested in social interaction and olfactory preference paradigms","pmids":["10869497"],"confidence":"Medium","gaps":["Circuit basis for social behavior phenotype unknown","Not replicated independently","Contribution of compensatory NMBR signaling not assessed"]},{"year":2004,"claim":"Identification of key ligand-binding residues (K101, Q121, A198, P199, S293, R288, T297) defined the structural determinants of GRP selectivity over related bombesin receptors.","evidence":"Site-directed mutagenesis with radioligand binding and reverse mutations in BRS-3","pmids":["15670577"],"confidence":"High","gaps":["No crystal or cryo-EM structure available","Mechanism by which individual residues contribute to selectivity not resolved at atomic level"]},{"year":2005,"claim":"Demonstration that brain GRPR signals through PLC/diacylglycerol lipase (not PLA2) to drive sympatho-adrenomedullary catecholamine release established tissue-specific signaling pathway utilization.","evidence":"Intracerebroventricular GRP injection with PLC and diacylglycerol lipase inhibitors, plasma catecholamine measurement","pmids":["15910801"],"confidence":"Medium","gaps":["Single lab pharmacological study","Cell type mediating central catecholamine response not identified"]},{"year":2011,"claim":"Discovery that MOR1D heterodimerizes with GRPR and that morphine triggers co-internalization with unidirectional cross-activation through PLCβ3/IP3R3 established the molecular mechanism of opioid-induced itch.","evidence":"Co-immunoprecipitation, internalization assays, PLCβ3/IP3R3 KO mice, behavioral assays","pmids":["22000021"],"confidence":"High","gaps":["Structural basis of MOR1D-GRPR heterodimer unknown","Relevance to human opioid-induced pruritus not directly tested"]},{"year":2011,"claim":"GRPR was shown to mediate GRP-induced neutrophil chemotaxis via PLC-β2, PI3K, ERK, and p38 in a Gαi-independent manner, extending GRPR function to innate immune cell recruitment.","evidence":"In vitro chemotaxis with pharmacological inhibitors and in vivo peritoneal neutrophil recruitment blocked by GRPR antagonist RC-3095","pmids":["22203955"],"confidence":"High","gaps":["Direct G protein coupling in neutrophils not characterized","Role in human neutrophil chemotaxis not confirmed"]},{"year":2013,"claim":"Electrophysiological dissection in paraventricular thalamic neurons revealed that GRPR activation suppresses an inward rectifier K+ conductance and activates a TRPV1-like non-selective cation conductance, defining the ionic basis of GRP-mediated excitation.","evidence":"Perforated patch clamp in acute brain slices with TRPV1 and BB2 antagonists","pmids":["23359674"],"confidence":"High","gaps":["Whether the same ionic mechanisms operate in spinal GRPR+ neurons is untested","Identity of the TRPV1-like channel not molecularly confirmed"]},{"year":2014,"claim":"Three studies collectively defined the circuit logic of spinal itch: 5-HT1A-GRPR heteromers potentiate itch signaling, GRPR and NMBR cross-compensate for histaminergic itch, and BNP-NPRA signaling operates independently of the GRP-GRPR pathway.","evidence":"FRET/calcium imaging for 5-HT1A-GRPR interaction; double KO mice for GRPR-NMBR epistasis; pharmacological/genetic blockade for BNP independence","pmids":["25453842","25209280","24438367"],"confidence":"High","gaps":["Whether 5-HT1A-GRPR heteromerization occurs in human spinal cord is unknown","How GRPR and NMBR cross-inhibit each other biochemically is unresolved"]},{"year":2015,"claim":"Identification of PI3Kγ/Akt as a GRPR effector pathway in spinal neurons and DRG neurons expanded the signaling repertoire beyond PLC, showing that GRP directly depolarizes small DRG neurons and induces Akt phosphorylation.","evidence":"Patch clamp, calcium imaging, Akt phosphorylation in ex vivo spinal cord and GRPR-transfected HEK293 cells, PI3Kγ inhibitor reduces scratching","pmids":["26658875"],"confidence":"High","gaps":["Whether PI3Kγ acts in parallel or downstream of PLCβ not resolved","DRG GRPR role in itch versus pain not fully dissected"]},{"year":2016,"claim":"GRPR activation was shown to drive epithelial-to-mesenchymal transition in prostate cancer cells by upregulating TWIST, SNAIL, and SLUG while downregulating E-cadherin, linking receptor signaling to cancer invasion.","evidence":"Stable GRPR transfection in Ace-1 cells, qRT-PCR for EMT markers, in vivo xenograft tumor growth","pmids":["26939805"],"confidence":"Medium","gaps":["Downstream signaling pathway mediating EMT not identified","Relevance to clinical prostate cancer progression not validated"]},{"year":2019,"claim":"Circuit mapping established that spinal GRPR+ neurons receive C/Aδ fiber input, contact NK1R+ projection neurons, and are gated by local galanin+ GABAergic, nNOS+ inhibitory, and descending RVM inhibitory neurons, defining the inhibitory control architecture of itch transmission.","evidence":"Electrophysiology, viral tracing, immunohistochemistry, GABAergic pharmacology in spinal cord","pmids":["31676846","31806757"],"confidence":"High","gaps":["Identity of descending RVM cell types projecting to GRPR+ neurons not fully resolved","Whether GRPR+ neuron gating differs in chronic itch states is unknown"]},{"year":2022,"claim":"Genetic cell-type identification confirmed GRPR+ neurons as glutamatergic vertical cells in laminae I–outer II that respond to both noxious and pruritic stimuli and whose chemogenetic activation evokes pain and itch behaviors, resolving their modality tuning.","evidence":"GRPR-CreERT2 mice, viral tracing, electrophysiology, DREADD chemogenetics, behavioral assays","pmids":["35543635"],"confidence":"High","gaps":["How GRPR+ neurons differentially encode itch versus pain at the population level is unresolved","Contribution of non-GRP ligands to GRPR+ neuron activation in vivo unknown"]},{"year":2023,"claim":"GRPR was linked to organ inflammation and injury through three distinct mechanisms: GRPR-TLR4/STAT1-mediated necroptosis in kidney tubular cells, IRF1/Caspase-1 and NOX2-dependent pathways in alcohol-associated liver injury, and NF-κB-driven renal fibrosis in hyperuricemia, with STAT1 establishing a positive feedback loop by inducing GRP synthesis.","evidence":"Global and conditional Grpr KO mice, Co-IP for GRPR-TLR4, ChIP for STAT1, GRPR overexpression rescue, pharmacological antagonist RH-1402, RNA-seq","pmids":["37409771","37415332","38084678"],"confidence":"High","gaps":["Whether GRPR-TLR4 interaction is direct or scaffolded not resolved","Human relevance of renal and hepatic GRPR pathology requires clinical validation","Specificity of STAT1 feedback loop to GRPR versus other bombesin receptors untested"]},{"year":2023,"claim":"Microglial NLRP3/caspase-1/IL-1β signaling was shown to enhance GRPR+ neuron activation via IL-1R1 in chronic itch, revealing a neuroimmune amplification loop.","evidence":"NLRP3/caspase-1 inhibitors, Grpr-eGFP and Grpr KO mice, intrathecal IL-1β and IL-1R1 antagonist, RNAscope ISH","pmids":["36876522"],"confidence":"Medium","gaps":["Whether IL-1β directly modulates GRPR expression or signaling efficiency unknown","Single lab study, not independently replicated"]},{"year":null,"claim":"A high-resolution structure of GRPR bound to GRP or antagonist is lacking, and the mechanisms by which GRPR+ spinal neurons differentially encode itch versus pain at the population level remain unresolved.","evidence":"","pmids":[],"confidence":"Low","gaps":["No cryo-EM or crystal structure of GRPR","Population coding logic of GRPR+ neurons for itch versus pain undefined","Therapeutic targeting of GRPR in chronic itch or organ inflammation lacks clinical trial data"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0060089","term_label":"molecular transducer activity","supporting_discovery_ids":[0,1,4,5,9]},{"term_id":"GO:0098772","term_label":"molecular function regulator activity","supporting_discovery_ids":[3,12]}],"localization":[{"term_id":"GO:0005886","term_label":"plasma membrane","supporting_discovery_ids":[8,15]},{"term_id":"GO:0005829","term_label":"cytosol","supporting_discovery_ids":[5]}],"pathway":[{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[0,1,4,5,9,10,12,13]},{"term_id":"R-HSA-168256","term_label":"Immune System","supporting_discovery_ids":[4,12,17]},{"term_id":"R-HSA-112316","term_label":"Neuronal System","supporting_discovery_ids":[6,7,18]},{"term_id":"R-HSA-5357801","term_label":"Programmed Cell Death","supporting_discovery_ids":[12]},{"term_id":"R-HSA-1643685","term_label":"Disease","supporting_discovery_ids":[11,16]}],"complexes":[],"partners":["OPRM1","HTR1A","NMBR","TLR4","PLCB3","ITPR3","PIK3CG"],"other_free_text":[]},"mechanistic_narrative":"GRPR is a G protein-coupled receptor for gastrin-releasing peptide (GRP) that functions as a central integrator of itch signaling in spinal cord circuits, a mediator of neutrophil chemotaxis, and a driver of cancer cell proliferation and organ inflammation. Ligand binding activates PLC/IP3, PI3Kγ/Akt, ERK/MAPK, and NF-κB signaling cascades, and high-affinity GRP recognition depends on extracellular/transmembrane residues K101, Q121, A198, P199, S293, R288, and T297 [PMID:15670577, PMID:26658875, PMID:22203955]. In the spinal dorsal horn, GRPR marks glutamatergic vertical interneurons in laminae I–II that receive nociceptive primary afferent input and are gated by local GABAergic (galanin+, nNOS+) and descending inhibitory neurons; GRPR heterodimerizes with MOR1D to mediate opioid-induced itch and with 5-HT1A to potentiate serotonergic itch facilitation [PMID:22000021, PMID:25453842, PMID:35543635, PMID:31676846, PMID:31806757]. Beyond itch, GRPR-TLR4 interaction activates STAT1 to drive necroptosis and inflammation in kidney injury, GRPR promotes epithelial-to-mesenchymal transition via TWIST/SNAIL/SLUG upregulation in prostate cancer, and GRPR signals through IRF1/Caspase-1 and NOX2 pathways to exacerbate alcohol-associated liver injury [PMID:37409771, PMID:37415332, PMID:26939805, PMID:38084678]."},"prefetch_data":{"uniprot":{"accession":"P30550","full_name":"Gastrin-releasing peptide receptor","aliases":["GRP-preferring bombesin receptor"],"length_aa":384,"mass_kda":43.2,"function":"Receptor for gastrin-releasing peptide (GRP) (PubMed:1655761). Signals via association with G proteins that activate a phosphatidylinositol-calcium second messenger system, resulting in Akt phosphorylation. Contributes to the regulation of food intake. Contributes to the perception of prurient stimuli and transmission of itch signals in the spinal cord that promote scratching behavior, but does not play a role in the perception of pain. Contributes primarily to nonhistaminergic itch sensation. In one study, shown to act in the amygdala as part of an inhibitory network which inhibits memory specifically related to learned fear (By similarity). In another study, shown to contribute to disinhibition of glutamatergic cells in the auditory cortex via signaling on vasoactive intestinal peptide-expressing cells which leads to enhanced auditory fear memories (By similarity). Contributes to the induction of sighing through signaling in the pre-Botzinger complex, a cluster of several thousand neurons in the ventrolateral medulla responsible for inspiration during respiratory activity (By similarity)","subcellular_location":"Cell membrane","url":"https://www.uniprot.org/uniprotkb/P30550/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/GRPR","classification":"Not Classified","n_dependent_lines":0,"n_total_lines":1208,"dependency_fraction":0.0},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/GRPR","total_profiled":1310},"omim":[{"mim_id":"607563","title":"SOLUTE CARRIER FAMILY 17 (VESICULAR GLUTAMATE COTRANSPORTER), MEMBER 6; SLC17A6","url":"https://www.omim.org/entry/607563"},{"mim_id":"312750","title":"RETT SYNDROME; RTT","url":"https://www.omim.org/entry/312750"},{"mim_id":"305670","title":"GASTRIN-RELEASING PEPTIDE RECEPTOR; GRPR","url":"https://www.omim.org/entry/305670"},{"mim_id":"300170","title":"OFD1 CENTRIOLE AND CENTRIOLAR SATELLITE PROTEIN; OFD1","url":"https://www.omim.org/entry/300170"},{"mim_id":"162341","title":"NEUROMEDIN B RECEPTOR; NMBR","url":"https://www.omim.org/entry/162341"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Supported","locations":[{"location":"Plasma membrane","reliability":"Supported"}],"tissue_specificity":"Tissue enriched","tissue_distribution":"Detected in some","driving_tissues":[{"tissue":"pancreas","ntpm":19.1}],"url":"https://www.proteinatlas.org/search/GRPR"},"hgnc":{"alias_symbol":["BB2","BB2R","BRS2"],"prev_symbol":[]},"alphafold":{"accession":"P30550","domains":[{"cath_id":"1.20.1070.10","chopping":"40-176_204-242_255-336","consensus_level":"high","plddt":92.8348,"start":40,"end":336}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/P30550","model_url":"https://alphafold.ebi.ac.uk/files/AF-P30550-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-P30550-F1-predicted_aligned_error_v6.png","plddt_mean":78.5},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=GRPR","jax_strain_url":"https://www.jax.org/strain/search?query=GRPR"},"sequence":{"accession":"P30550","fasta_url":"https://rest.uniprot.org/uniprotkb/P30550.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/P30550/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/P30550"}},"corpus_meta":[{"pmid":"22000021","id":"PMC_22000021","title":"Unidirectional cross-activation of GRPR by MOR1D uncouples itch and analgesia induced by opioids.","date":"2011","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/22000021","citation_count":210,"is_preprint":false},{"pmid":"20717822","id":"PMC_20717822","title":"Development of a potent DOTA-conjugated bombesin antagonist for targeting GRPr-positive tumours.","date":"2010","source":"European journal of nuclear medicine and molecular imaging","url":"https://pubmed.ncbi.nlm.nih.gov/20717822","citation_count":164,"is_preprint":false},{"pmid":"16818949","id":"PMC_16818949","title":"177Lu-AMBA: Synthesis and characterization of a selective 177Lu-labeled GRP-R agonist for systemic radiotherapy of prostate cancer.","date":"2006","source":"Journal of nuclear medicine : official publication, Society of Nuclear Medicine","url":"https://pubmed.ncbi.nlm.nih.gov/16818949","citation_count":164,"is_preprint":false},{"pmid":"19360404","id":"PMC_19360404","title":"(68)Ga-labeled NOTA-RGD-BBN peptide for dual integrin and GRPR-targeted tumor imaging.","date":"2009","source":"European journal of nuclear medicine and molecular imaging","url":"https://pubmed.ncbi.nlm.nih.gov/19360404","citation_count":120,"is_preprint":false},{"pmid":"27609789","id":"PMC_27609789","title":"68Ga/177Lu-NeoBOMB1, a Novel Radiolabeled GRPR Antagonist for Theranostic Use in Oncology.","date":"2016","source":"Journal of nuclear medicine : official publication, Society of Nuclear Medicine","url":"https://pubmed.ncbi.nlm.nih.gov/27609789","citation_count":103,"is_preprint":false},{"pmid":"24464532","id":"PMC_24464532","title":"Preclinical evaluation of a bispecific low-molecular heterodimer targeting both PSMA and GRPR for improved PET imaging and therapy of prostate cancer.","date":"2014","source":"The Prostate","url":"https://pubmed.ncbi.nlm.nih.gov/24464532","citation_count":95,"is_preprint":false},{"pmid":"23507930","id":"PMC_23507930","title":"Targeting GRPR in urological cancers--from basic research to clinical application.","date":"2013","source":"Nature reviews. Urology","url":"https://pubmed.ncbi.nlm.nih.gov/23507930","citation_count":95,"is_preprint":false},{"pmid":"25453842","id":"PMC_25453842","title":"Descending control of itch transmission by the serotonergic system via 5-HT1A-facilitated GRP-GRPR signaling.","date":"2014","source":"Neuron","url":"https://pubmed.ncbi.nlm.nih.gov/25453842","citation_count":94,"is_preprint":false},{"pmid":"29123014","id":"PMC_29123014","title":"PET Using a GRPR Antagonist 68Ga-RM26 in Healthy Volunteers and Prostate Cancer Patients.","date":"2017","source":"Journal of nuclear medicine : official publication, Society of Nuclear Medicine","url":"https://pubmed.ncbi.nlm.nih.gov/29123014","citation_count":89,"is_preprint":false},{"pmid":"23763444","id":"PMC_23763444","title":"Synthesis and characterization of a high-affinity NOTA-conjugated bombesin antagonist for GRPR-targeted tumor imaging.","date":"2013","source":"Bioconjugate chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/23763444","citation_count":71,"is_preprint":false},{"pmid":"21544226","id":"PMC_21544226","title":"F-Labeled GRPR Agonists and Antagonists: A Comparative Study in Prostate Cancer Imaging.","date":"2011","source":"Theranostics","url":"https://pubmed.ncbi.nlm.nih.gov/21544226","citation_count":70,"is_preprint":false},{"pmid":"22203955","id":"PMC_22203955","title":"Gastrin-releasing peptide receptor (GRPR) mediates chemotaxis in neutrophils.","date":"2011","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/22203955","citation_count":67,"is_preprint":false},{"pmid":"29464003","id":"PMC_29464003","title":"68Ga-BBN-RGD PET/CT for GRPR and Integrin αvβ3 Imaging in Patients with Breast Cancer.","date":"2018","source":"Theranostics","url":"https://pubmed.ncbi.nlm.nih.gov/29464003","citation_count":65,"is_preprint":false},{"pmid":"19910427","id":"PMC_19910427","title":"177Lu-AMBA biodistribution, radiotherapeutic efficacy, imaging, and autoradiography in prostate cancer models with low GRP-R expression.","date":"2009","source":"Journal of nuclear medicine : official publication, Society of Nuclear Medicine","url":"https://pubmed.ncbi.nlm.nih.gov/19910427","citation_count":64,"is_preprint":false},{"pmid":"31366895","id":"PMC_31366895","title":"Comparative Study of Subcutaneous and Orthotopic Mouse Models of Prostate Cancer: Vascular Perfusion, Vasculature Density, Hypoxic Burden and BB2r-Targeting Efficacy.","date":"2019","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/31366895","citation_count":58,"is_preprint":false},{"pmid":"24438367","id":"PMC_24438367","title":"B-type natriuretic peptide is neither itch-specific nor functions upstream of the GRP-GRPR signaling pathway.","date":"2014","source":"Molecular pain","url":"https://pubmed.ncbi.nlm.nih.gov/24438367","citation_count":58,"is_preprint":false},{"pmid":"31017093","id":"PMC_31017093","title":"Prospective Study of the Radiolabeled GRPR Antagonist BAY86-7548 for Positron Emission Tomography/Computed Tomography Imaging of Newly Diagnosed Prostate Cancer.","date":"2018","source":"European urology oncology","url":"https://pubmed.ncbi.nlm.nih.gov/31017093","citation_count":58,"is_preprint":false},{"pmid":"26726823","id":"PMC_26726823","title":"Novel Bispecific PSMA/GRPr Targeting Radioligands with Optimized Pharmacokinetics for Improved PET Imaging of Prostate Cancer.","date":"2016","source":"Bioconjugate chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/26726823","citation_count":56,"is_preprint":false},{"pmid":"33674398","id":"PMC_33674398","title":"PSMA- and GRPR-Targeted PET: Results from 50 Patients with Biochemically Recurrent Prostate Cancer.","date":"2021","source":"Journal of nuclear medicine : official publication, Society of Nuclear Medicine","url":"https://pubmed.ncbi.nlm.nih.gov/33674398","citation_count":53,"is_preprint":false},{"pmid":"25209280","id":"PMC_25209280","title":"Cross-inhibition of NMBR and GRPR signaling maintains normal histaminergic itch transmission.","date":"2014","source":"The Journal of neuroscience : the official journal of the Society for Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/25209280","citation_count":50,"is_preprint":false},{"pmid":"9873586","id":"PMC_9873586","title":"PD 176252--the first high affinity non-peptide gastrin-releasing peptide (BB2) receptor antagonist.","date":"1998","source":"Bioorganic & medicinal chemistry letters","url":"https://pubmed.ncbi.nlm.nih.gov/9873586","citation_count":46,"is_preprint":false},{"pmid":"31806757","id":"PMC_31806757","title":"Synaptic control of spinal GRPR+ neurons by local and long-range inhibitory inputs.","date":"2019","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/31806757","citation_count":46,"is_preprint":false},{"pmid":"24727373","id":"PMC_24727373","title":"PSMA, EpCAM, VEGF and GRPR as imaging targets in locally recurrent prostate cancer after radiotherapy.","date":"2014","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/24727373","citation_count":44,"is_preprint":false},{"pmid":"34124036","id":"PMC_34124036","title":"Exosomes Isolated From Bone Marrow Mesenchymal Stem Cells Exert a Protective Effect on Osteoarthritis via lncRNA LYRM4-AS1-GRPR-miR-6515-5p.","date":"2021","source":"Frontiers in cell and developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/34124036","citation_count":44,"is_preprint":false},{"pmid":"31540122","id":"PMC_31540122","title":"Bispecific GRPR-Antagonistic Anti-PSMA/GRPR Heterodimer for PET and SPECT Diagnostic Imaging of Prostate Cancer.","date":"2019","source":"Cancers","url":"https://pubmed.ncbi.nlm.nih.gov/31540122","citation_count":42,"is_preprint":false},{"pmid":"32649787","id":"PMC_32649787","title":"Peptide-Conjugated Long-Lived Theranostic Imaging for Targeting GRPr in Cancer and Immune Cells.","date":"2020","source":"Angewandte Chemie (International ed. in English)","url":"https://pubmed.ncbi.nlm.nih.gov/32649787","citation_count":41,"is_preprint":false},{"pmid":"24508213","id":"PMC_24508213","title":"Synthesis and biological evaluation of copper-64 radiolabeled [DUPA-6-Ahx-(NODAGA)-5-Ava-BBN(7-14)NH2], a novel bivalent targeting vector having affinity for two distinct biomarkers (GRPr/PSMA) of prostate cancer.","date":"2014","source":"Nuclear medicine and biology","url":"https://pubmed.ncbi.nlm.nih.gov/24508213","citation_count":40,"is_preprint":false},{"pmid":"31676846","id":"PMC_31676846","title":"Pain Inhibits GRPR Neurons via GABAergic Signaling in the Spinal Cord.","date":"2019","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/31676846","citation_count":38,"is_preprint":false},{"pmid":"24480266","id":"PMC_24480266","title":"A heterodimeric [RGD-Glu-[(64)Cu-NO2A]-6-Ahx-RM2] αvβ3/GRPr-targeting antagonist radiotracer for PET imaging of prostate tumors.","date":"2013","source":"Nuclear medicine and biology","url":"https://pubmed.ncbi.nlm.nih.gov/24480266","citation_count":38,"is_preprint":false},{"pmid":"24312607","id":"PMC_24312607","title":"In vitro and in vivo evaluation of a (18)F-labeled high affinity NOTA conjugated bombesin antagonist as a PET ligand for GRPR-targeted tumor imaging.","date":"2013","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/24312607","citation_count":37,"is_preprint":false},{"pmid":"33789933","id":"PMC_33789933","title":"GRPr Antagonist 68Ga-SB3 PET/CT Imaging of Primary Prostate Cancer in Therapy-Naïve Patients.","date":"2021","source":"Journal of nuclear medicine : official publication, Society of Nuclear Medicine","url":"https://pubmed.ncbi.nlm.nih.gov/33789933","citation_count":37,"is_preprint":false},{"pmid":"22248281","id":"PMC_22248281","title":"Immunohistochemical analysis of gastrin-releasing peptide receptor (GRPR) and possible regulation by estrogen receptor βcx in human prostate carcinoma.","date":"2012","source":"Neoplasma","url":"https://pubmed.ncbi.nlm.nih.gov/22248281","citation_count":37,"is_preprint":false},{"pmid":"34474862","id":"PMC_34474862","title":"Magnetic and GRPR-targeted reduced graphene oxide/doxorubicin nanocomposite for dual-targeted chemo-photothermal cancer therapy.","date":"2021","source":"Materials science & engineering. C, Materials for biological applications","url":"https://pubmed.ncbi.nlm.nih.gov/34474862","citation_count":33,"is_preprint":false},{"pmid":"9598980","id":"PMC_9598980","title":"Identification and location on syndecan-1 core protein of the epitopes of B-B2 and B-B4 monoclonal antibodies.","date":"1998","source":"FEBS letters","url":"https://pubmed.ncbi.nlm.nih.gov/9598980","citation_count":33,"is_preprint":false},{"pmid":"32032577","id":"PMC_32032577","title":"Spinal GRPR and NPRA Contribute to Chronic Itch in a Murine Model of Allergic Contact Dermatitis.","date":"2020","source":"The Journal of investigative dermatology","url":"https://pubmed.ncbi.nlm.nih.gov/32032577","citation_count":31,"is_preprint":false},{"pmid":"7759104","id":"PMC_7759104","title":"A 6-Mb YAC contig in Xp22.1-p22.2 spanning the DXS69E, XE59, GLRA2, PIGA, GRPR, CALB3, and PHKA2 genes.","date":"1995","source":"Genomics","url":"https://pubmed.ncbi.nlm.nih.gov/7759104","citation_count":31,"is_preprint":false},{"pmid":"19642024","id":"PMC_19642024","title":"BDNF and PDE4, but not the GRPR, regulate viability of human medulloblastoma cells.","date":"2009","source":"Journal of molecular neuroscience : MN","url":"https://pubmed.ncbi.nlm.nih.gov/19642024","citation_count":30,"is_preprint":false},{"pmid":"30645633","id":"PMC_30645633","title":"Comparison of the binding of the gastrin-releasing peptide receptor (GRP-R) antagonist 68Ga-RM2 and 18F-FDG in breast cancer samples.","date":"2019","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/30645633","citation_count":30,"is_preprint":false},{"pmid":"37409771","id":"PMC_37409771","title":"GRP/GRPR enhances alcohol-associated liver injury through the IRF1-mediated Caspase-1 inflammasome and NOX2-dependent ROS pathway.","date":"2023","source":"Hepatology (Baltimore, Md.)","url":"https://pubmed.ncbi.nlm.nih.gov/37409771","citation_count":29,"is_preprint":false},{"pmid":"36876522","id":"PMC_36876522","title":"Microglia-neuron interactions promote chronic itch via the NLRP3-IL-1β-GRPR axis.","date":"2023","source":"Allergy","url":"https://pubmed.ncbi.nlm.nih.gov/36876522","citation_count":29,"is_preprint":false},{"pmid":"26939805","id":"PMC_26939805","title":"Gastrin-releasing peptide receptor (GRPr) promotes EMT, growth, and invasion in canine prostate cancer.","date":"2016","source":"The Prostate","url":"https://pubmed.ncbi.nlm.nih.gov/26939805","citation_count":29,"is_preprint":false},{"pmid":"24533789","id":"PMC_24533789","title":"PESIN multimerization improves receptor avidities and in vivo tumor targeting properties to GRPR-overexpressing tumors.","date":"2014","source":"Bioconjugate chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/24533789","citation_count":29,"is_preprint":false},{"pmid":"26897133","id":"PMC_26897133","title":"Pre-clinical evaluation of eight DOTA coupled gastrin-releasing peptide receptor (GRP-R) ligands for in vivo targeting of receptor-expressing tumors.","date":"2016","source":"EJNMMI research","url":"https://pubmed.ncbi.nlm.nih.gov/26897133","citation_count":28,"is_preprint":false},{"pmid":"29097932","id":"PMC_29097932","title":"High Contrast PET Imaging of GRPR Expression in Prostate Cancer Using Cobalt-Labeled Bombesin Antagonist RM26.","date":"2017","source":"Contrast media & molecular imaging","url":"https://pubmed.ncbi.nlm.nih.gov/29097932","citation_count":28,"is_preprint":false},{"pmid":"32630176","id":"PMC_32630176","title":"Heterodimeric Radiotracer Targeting PSMA and GRPR for Imaging of Prostate Cancer-Optimization of the Affinity towards PSMA by Linker Modification in Murine Model.","date":"2020","source":"Pharmaceutics","url":"https://pubmed.ncbi.nlm.nih.gov/32630176","citation_count":28,"is_preprint":false},{"pmid":"26658875","id":"PMC_26658875","title":"GRPR/PI3Kγ: Partners in Central Transmission of Itch.","date":"2015","source":"The Journal of neuroscience : the official journal of the Society for Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/26658875","citation_count":28,"is_preprint":false},{"pmid":"31161459","id":"PMC_31161459","title":"Comparison of the radiolabeled PSMA-inhibitor 111In-PSMA-617 and the radiolabeled GRP-R antagonist 111In-RM2 in primary prostate cancer samples.","date":"2019","source":"EJNMMI research","url":"https://pubmed.ncbi.nlm.nih.gov/31161459","citation_count":28,"is_preprint":false},{"pmid":"36933382","id":"PMC_36933382","title":"Novel insight on GRP/GRPR axis in diseases.","date":"2023","source":"Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie","url":"https://pubmed.ncbi.nlm.nih.gov/36933382","citation_count":27,"is_preprint":false},{"pmid":"35543635","id":"PMC_35543635","title":"Grpr expression defines a population of superficial dorsal horn vertical cells that have a role in both itch and pain.","date":"2022","source":"Pain","url":"https://pubmed.ncbi.nlm.nih.gov/35543635","citation_count":27,"is_preprint":false},{"pmid":"28500250","id":"PMC_28500250","title":"Characterization of NMB, GRP and their receptors (BRS3, NMBR and GRPR) in chickens.","date":"2017","source":"Journal of molecular endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/28500250","citation_count":27,"is_preprint":false},{"pmid":"24633452","id":"PMC_24633452","title":"A new (68)Ga-labeled BBN peptide with a hydrophilic linker for GRPR-targeted tumor imaging.","date":"2014","source":"Amino acids","url":"https://pubmed.ncbi.nlm.nih.gov/24633452","citation_count":27,"is_preprint":false},{"pmid":"29137110","id":"PMC_29137110","title":"NeoBOMB1, a GRPR-Antagonist for Breast Cancer Theragnostics: First Results of a Preclinical Study with [67Ga]NeoBOMB1 in T-47D Cells and Tumor-Bearing Mice.","date":"2017","source":"Molecules (Basel, Switzerland)","url":"https://pubmed.ncbi.nlm.nih.gov/29137110","citation_count":27,"is_preprint":false},{"pmid":"34680243","id":"PMC_34680243","title":"[99mTc]Tc-DB15 in GRPR-Targeted Tumor Imaging with SPECT: From Preclinical Evaluation to the First Clinical Outcomes.","date":"2021","source":"Cancers","url":"https://pubmed.ncbi.nlm.nih.gov/34680243","citation_count":26,"is_preprint":false},{"pmid":"20857927","id":"PMC_20857927","title":"In vitro and in vivo characterization of novel 18F-labeled bombesin analogues for targeting GRPR-positive tumors.","date":"2010","source":"Bioconjugate chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/20857927","citation_count":26,"is_preprint":false},{"pmid":"31340483","id":"PMC_31340483","title":"Synthesis and Preclinical Evaluation of Radio-Iodinated GRPR/PSMA Bispecific Heterodimers for the Theranostics Application in Prostate Cancer.","date":"2019","source":"Pharmaceutics","url":"https://pubmed.ncbi.nlm.nih.gov/31340483","citation_count":25,"is_preprint":false},{"pmid":"36980517","id":"PMC_36980517","title":"Phase I Trial of [99mTc]Tc-maSSS-PEG2-RM26, a Bombesin Analogue Antagonistic to Gastrin-Releasing Peptide Receptors (GRPRs), for SPECT Imaging of GRPR Expression in Malignant Tumors.","date":"2023","source":"Cancers","url":"https://pubmed.ncbi.nlm.nih.gov/36980517","citation_count":25,"is_preprint":false},{"pmid":"16967266","id":"PMC_16967266","title":"Immunohistochemical detection of bombesin receptor subtypes GRP-R and BRS-3 in human tumors using novel antipeptide antibodies.","date":"2006","source":"Virchows Archiv : an international journal of pathology","url":"https://pubmed.ncbi.nlm.nih.gov/16967266","citation_count":25,"is_preprint":false},{"pmid":"10869497","id":"PMC_10869497","title":"Male mice lacking the gastrin-releasing peptide receptor (GRP-R) display elevated preference for conspecific odors and increased social investigatory behaviors.","date":"2000","source":"Brain research","url":"https://pubmed.ncbi.nlm.nih.gov/10869497","citation_count":25,"is_preprint":false},{"pmid":"15670577","id":"PMC_15670577","title":"Identification of key amino acids in the gastrin-releasing peptide receptor (GRPR) responsible for high affinity binding of gastrin-releasing peptide (GRP).","date":"2004","source":"Biochemical pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/15670577","citation_count":24,"is_preprint":false},{"pmid":"38020178","id":"PMC_38020178","title":"GRPR-targeting radiotheranostics for breast cancer management.","date":"2023","source":"Frontiers in medicine","url":"https://pubmed.ncbi.nlm.nih.gov/38020178","citation_count":24,"is_preprint":false},{"pmid":"23359674","id":"PMC_23359674","title":"Gastrin-releasing peptide acts via postsynaptic BB2 receptors to modulate inward rectifier K+ and TRPV1-like conductances in rat paraventricular thalamic neurons.","date":"2013","source":"The Journal of physiology","url":"https://pubmed.ncbi.nlm.nih.gov/23359674","citation_count":23,"is_preprint":false},{"pmid":"9479493","id":"PMC_9479493","title":"Human FIGF: cloning, gene structure, and mapping to chromosome Xp22.1 between the PIGA and the GRPR genes.","date":"1998","source":"Genomics","url":"https://pubmed.ncbi.nlm.nih.gov/9479493","citation_count":23,"is_preprint":false},{"pmid":"37415332","id":"PMC_37415332","title":"Genetic and pharmacological inhibition of GRPR protects against acute kidney injury via attenuating renal inflammation and necroptosis.","date":"2023","source":"Molecular therapy : the journal of the American Society of Gene Therapy","url":"https://pubmed.ncbi.nlm.nih.gov/37415332","citation_count":22,"is_preprint":false},{"pmid":"36834815","id":"PMC_36834815","title":"Targeting the Gastrin-Releasing Peptide Receptor (GRP-R) in Cancer Therapy: Development of Bombesin-Based Peptide-Drug Conjugates.","date":"2023","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/36834815","citation_count":22,"is_preprint":false},{"pmid":"31745219","id":"PMC_31745219","title":"Selection of an optimal macrocyclic chelator improves the imaging of prostate cancer using cobalt-labeled GRPR antagonist RM26.","date":"2019","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/31745219","citation_count":22,"is_preprint":false},{"pmid":"26577829","id":"PMC_26577829","title":"GRPR-targeted Protein Contrast Agents for Molecular Imaging of Receptor Expression in Cancers by MRI.","date":"2015","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/26577829","citation_count":22,"is_preprint":false},{"pmid":"27399868","id":"PMC_27399868","title":"Preclinical Study on GRPR-Targeted (68)Ga-Probes for PET Imaging of Prostate Cancer.","date":"2016","source":"Bioconjugate chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/27399868","citation_count":21,"is_preprint":false},{"pmid":"25474596","id":"PMC_25474596","title":"Evaluation of three different families of bombesin receptor radioantagonists for targeted imaging and therapy of gastrin releasing peptide receptor (GRP-R) positive tumors.","date":"2014","source":"Journal of medicinal chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/25474596","citation_count":21,"is_preprint":false},{"pmid":"8830734","id":"PMC_8830734","title":"Efficacy and toxicity of plasma-cell-reactive monoclonal antibodies B-B2 and B-B4 and their immunotoxins.","date":"1996","source":"Cancer immunology, immunotherapy : CII","url":"https://pubmed.ncbi.nlm.nih.gov/8830734","citation_count":21,"is_preprint":false},{"pmid":"38536552","id":"PMC_38536552","title":"IL-6 Enhances the Activation of PI3K-AKT/mTOR-GSK-3β by Upregulating GRPR in Hippocampal Neurons of Autistic Mice.","date":"2024","source":"Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/38536552","citation_count":20,"is_preprint":false},{"pmid":"8406441","id":"PMC_8406441","title":"Comparative mapping of the Grpr locus on the X chromosomes of man and mouse.","date":"1993","source":"Genomics","url":"https://pubmed.ncbi.nlm.nih.gov/8406441","citation_count":20,"is_preprint":false},{"pmid":"33595022","id":"PMC_33595022","title":"GRPr-mediated photothermal and thermodynamic dual-therapy for prostate cancer with synergistic anti-apoptosis mechanism.","date":"2021","source":"Nanoscale","url":"https://pubmed.ncbi.nlm.nih.gov/33595022","citation_count":19,"is_preprint":false},{"pmid":"37934025","id":"PMC_37934025","title":"Preclinical Comparison of the 64Cu- and 68Ga-Labeled GRPR-Targeted Compounds RM2 and AMTG, as Well as First-in-Humans [68Ga]Ga-AMTG PET/CT.","date":"2023","source":"Journal of nuclear medicine : official publication, Society of Nuclear Medicine","url":"https://pubmed.ncbi.nlm.nih.gov/37934025","citation_count":19,"is_preprint":false},{"pmid":"33801382","id":"PMC_33801382","title":"In Vivo Biodistribution and Efficacy Evaluation of NeoB, a Radiotracer Targeted to GRPR, in Mice Bearing Gastrointestinal Stromal Tumor.","date":"2021","source":"Cancers","url":"https://pubmed.ncbi.nlm.nih.gov/33801382","citation_count":19,"is_preprint":false},{"pmid":"23590837","id":"PMC_23590837","title":"Preclinical evaluation of a novel ¹¹¹In-labeled bombesin homodimer for improved imaging of GRPR-positive prostate cancer.","date":"2013","source":"Molecular pharmaceutics","url":"https://pubmed.ncbi.nlm.nih.gov/23590837","citation_count":19,"is_preprint":false},{"pmid":"38442298","id":"PMC_38442298","title":"Gastrin-releasing peptide receptor (GRPR) as a novel biomarker and therapeutic target in prostate cancer.","date":"2024","source":"Annals of medicine","url":"https://pubmed.ncbi.nlm.nih.gov/38442298","citation_count":18,"is_preprint":false},{"pmid":"24649138","id":"PMC_24649138","title":"Influence of GRPR and BDNF/TrkB signaling on the viability of breast and gynecologic cancer cells.","date":"2012","source":"Molecular and clinical oncology","url":"https://pubmed.ncbi.nlm.nih.gov/24649138","citation_count":18,"is_preprint":false},{"pmid":"32301469","id":"PMC_32301469","title":"Characterization of the Fe metalloproteome of a ubiquitous marine heterotroph, Pseudoalteromonas (BB2-AT2): multiple bacterioferritin copies enable significant Fe storage.","date":"2020","source":"Metallomics : integrated biometal science","url":"https://pubmed.ncbi.nlm.nih.gov/32301469","citation_count":18,"is_preprint":false},{"pmid":"35744904","id":"PMC_35744904","title":"68Ga-Labeled [Leu13ψThz14]Bombesin(7-14) Derivatives: Promising GRPR-Targeting PET Tracers with Low Pancreas Uptake.","date":"2022","source":"Molecules (Basel, Switzerland)","url":"https://pubmed.ncbi.nlm.nih.gov/35744904","citation_count":18,"is_preprint":false},{"pmid":"33039402","id":"PMC_33039402","title":"GRPR/Extracellular Signal-Regulated Kinase and NPRA/Extracellular Signal-Regulated Kinase Signaling Pathways Play a Critical Role in Spinal Transmission of Chronic Itch.","date":"2020","source":"The Journal of investigative dermatology","url":"https://pubmed.ncbi.nlm.nih.gov/33039402","citation_count":18,"is_preprint":false},{"pmid":"38169486","id":"PMC_38169486","title":"Lower-grade gliomas surgery guided by GRPR-targeting PET/NIR dual-modality image probe: a prospective and single-arm clinical trial.","date":"2024","source":"Theranostics","url":"https://pubmed.ncbi.nlm.nih.gov/38169486","citation_count":17,"is_preprint":false},{"pmid":"33534560","id":"PMC_33534560","title":"Development of Heterobivalent Theranostic Probes Having High Affinity/Selectivity for the GRPR/PSMA.","date":"2021","source":"Journal of medicinal chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/33534560","citation_count":17,"is_preprint":false},{"pmid":"18452185","id":"PMC_18452185","title":"Association and linkage analysis of candidate genes GRP, GRPR, CRHR1, and TACR1 in panic disorder.","date":"2009","source":"American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics","url":"https://pubmed.ncbi.nlm.nih.gov/18452185","citation_count":17,"is_preprint":false},{"pmid":"22833158","id":"PMC_22833158","title":"Evaluation of a technetium-99m labeled bombesin homodimer for GRPR imaging in prostate cancer.","date":"2012","source":"Amino acids","url":"https://pubmed.ncbi.nlm.nih.gov/22833158","citation_count":17,"is_preprint":false},{"pmid":"28294319","id":"PMC_28294319","title":"GRPR antagonist protects from drug-induced liver injury by impairing neutrophil chemotaxis and motility.","date":"2017","source":"European journal of immunology","url":"https://pubmed.ncbi.nlm.nih.gov/28294319","citation_count":16,"is_preprint":false},{"pmid":"31270559","id":"PMC_31270559","title":"68Ga-NOTA-Aca-BBN(7-14) PET imaging of GRPR in children with optic pathway glioma.","date":"2019","source":"European journal of nuclear medicine and molecular imaging","url":"https://pubmed.ncbi.nlm.nih.gov/31270559","citation_count":16,"is_preprint":false},{"pmid":"25426011","id":"PMC_25426011","title":"The Gastrin-Releasing Peptide Receptor (GRPR) in the Spinal Cord as a Novel Pharmacological Target.","date":"2014","source":"Current neuropharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/25426011","citation_count":16,"is_preprint":false},{"pmid":"32618007","id":"PMC_32618007","title":"Functional Hybrid Molecules for the Visualization of Cancer: PESIN-Homodimers Combined with Multimodal Molecular Imaging Probes for Positron Emission Tomography and Optical Imaging: Suited for Tracking of GRPR-Positive Malignant Tissue*.","date":"2020","source":"Chemistry (Weinheim an der Bergstrasse, Germany)","url":"https://pubmed.ncbi.nlm.nih.gov/32618007","citation_count":16,"is_preprint":false},{"pmid":"38376806","id":"PMC_38376806","title":"Synthesis, preclinical, and initial clinical evaluation of integrin αVβ3 and gastrin-releasing peptide receptor (GRPR) dual-targeting radiotracer [68Ga]Ga-RGD-RM26-03.","date":"2024","source":"European journal of nuclear medicine and molecular imaging","url":"https://pubmed.ncbi.nlm.nih.gov/38376806","citation_count":16,"is_preprint":false},{"pmid":"33664646","id":"PMC_33664646","title":"100 Hz Electroacupuncture Alleviated Chronic Itch and GRPR Expression Through Activation of Kappa Opioid Receptors in Spinal Dorsal Horn.","date":"2021","source":"Frontiers in neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/33664646","citation_count":15,"is_preprint":false},{"pmid":"33140758","id":"PMC_33140758","title":"GRPR-targeted SPECT imaging using a novel bombesin-based peptide for colorectal cancer detection.","date":"2020","source":"Biomaterials science","url":"https://pubmed.ncbi.nlm.nih.gov/33140758","citation_count":15,"is_preprint":false},{"pmid":"11763364","id":"PMC_11763364","title":"Discovery of potent and selective peptide agonists at the GRP-preferring bombesin receptor (BB2).","date":"2001","source":"Journal of peptide science : an official publication of the European Peptide Society","url":"https://pubmed.ncbi.nlm.nih.gov/11763364","citation_count":14,"is_preprint":false},{"pmid":"33573232","id":"PMC_33573232","title":"Preclinical Evaluation of 99mTc-Labeled GRPR Antagonists maSSS/SES-PEG2-RM26 for Imaging of Prostate Cancer.","date":"2021","source":"Pharmaceutics","url":"https://pubmed.ncbi.nlm.nih.gov/33573232","citation_count":14,"is_preprint":false},{"pmid":"28636973","id":"PMC_28636973","title":"Amide-to-triazole switch vs. in vivo NEP-inhibition approaches to promote radiopeptide targeting of GRPR-positive tumors.","date":"2017","source":"Nuclear medicine and biology","url":"https://pubmed.ncbi.nlm.nih.gov/28636973","citation_count":14,"is_preprint":false},{"pmid":"29154145","id":"PMC_29154145","title":"Evaluation of a novel GRPR antagonist for prostate cancer PET imaging: [64Cu]-DOTHA2-PEG-RM26.","date":"2017","source":"Nuclear medicine and biology","url":"https://pubmed.ncbi.nlm.nih.gov/29154145","citation_count":14,"is_preprint":false},{"pmid":"32886303","id":"PMC_32886303","title":"Development and Preclinical Evaluation of 99mTc- and 186Re-Labeled NOTA and NODAGA Bioconjugates Demonstrating Matched Pair Targeting of GRPR-Expressing Tumors.","date":"2020","source":"Molecular imaging and biology","url":"https://pubmed.ncbi.nlm.nih.gov/32886303","citation_count":14,"is_preprint":false},{"pmid":"38084678","id":"PMC_38084678","title":"GRP/GRPR signaling pathway aggravates hyperuricemia-induced renal inflammation and fibrosis via ABCG2-dependent mechanisms.","date":"2023","source":"Biochemical pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/38084678","citation_count":13,"is_preprint":false},{"pmid":"33574368","id":"PMC_33574368","title":"66Ga-PET-imaging of GRPR-expression in prostate cancer: production and characterization of [66Ga]Ga-NOTA-PEG2-RM26.","date":"2021","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/33574368","citation_count":13,"is_preprint":false},{"pmid":"15910801","id":"PMC_15910801","title":"Brain phospholipase C/diacylglycerol lipase are involved in bombesin BB2 receptor-mediated activation of sympatho-adrenomedullary outflow in rats.","date":"2005","source":"European journal of pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/15910801","citation_count":13,"is_preprint":false},{"pmid":"37516088","id":"PMC_37516088","title":"Antipruritic effects of geraniol on acute and chronic itch via modulating spinal GABA/GRPR signaling.","date":"2023","source":"Phytomedicine : international journal of phytotherapy and phytopharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/37516088","citation_count":13,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":61516,"output_tokens":4890,"usd":0.128949},"stage2":{"model":"claude-opus-4-6","input_tokens":8427,"output_tokens":3640,"usd":0.199703},"total_usd":0.328652,"stage1_batch_id":"msgbatch_01DzrsgVgYngY1hvM3DU1yF2","stage2_batch_id":"msgbatch_01KA9b7iRzKFdhoBUT7vCvSe","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2011,\n      \"finding\": \"MOR1D heterodimerizes with GRPR in the spinal cord, and morphine triggers co-internalization of both MOR1D and GRPR, whereas GRP specifically triggers only GRPR internalization. This heterodimerization mediates opioid-induced itch via unidirectional cross-activation of GRPR signaling by MOR1D, downstream through PLCβ3 and IP3R3.\",\n      \"method\": \"Co-immunoprecipitation, receptor internalization assays, genetic and pharmacologic inhibition of PLCβ3/IP3R3, behavioral assays in knockout mice\",\n      \"journal\": \"Cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — reciprocal Co-IP, multiple orthogonal methods (internalization, pharmacologic blockade, KO mice), replicated in behavioral and biochemical contexts\",\n      \"pmids\": [\"22000021\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"5-HT1A and GRPR form receptor heteromeric complexes in spinal cord neurons; co-activation of 5-HT1A and GRPR greatly potentiates subthreshold GRP-induced Ca2+ transients and action potential firing in GRPR+ neurons, establishing a descending serotonergic facilitation of GRP-GRPR itch signaling.\",\n      \"method\": \"Immunostaining, biochemical co-localization, biophysical/FRET studies, calcium imaging, pharmacological and behavioral screening\",\n      \"journal\": \"Neuron\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal methods including biochemical interaction, calcium imaging, electrophysiology, and behavioral assays in one study\",\n      \"pmids\": [\"25453842\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"Pharmacological and genetic blockade of GRP-GRPR signaling does not significantly affect intrathecal BNP-induced scratching, demonstrating that BNP-NPRA signaling does not function upstream of the GRP-GRPR dedicated neuronal pathway for itch.\",\n      \"method\": \"Pharmacological blockade, genetic knockout, intrathecal injection behavioral assays, in situ hybridization, RT-PCR\",\n      \"journal\": \"Molecular pain\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — genetic and pharmacologic epistasis with behavioral readout, single lab study\",\n      \"pmids\": [\"24438367\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"GRPR and NMBR cross-inhibit each other's signaling; in double-knockout mice lacking both Nmbr and Grpr, histaminergic itch is significantly reduced, demonstrating that GRPR and NMBR compensate for each other to maintain normal histamine-evoked itch. GRPR activity is enhanced in Nmbr KO mice and vice versa. GRP can signal through both GRPR and NMBR, while GRPR+ neurons act downstream of NMBR+ neurons in histaminergic itch circuits.\",\n      \"method\": \"Double knockout mice, single knockout mice behavioral assays, pharmacological scratching assays, GRPR expression analysis\",\n      \"journal\": \"The Journal of neuroscience\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — genetic epistasis with double KO and multiple behavioral readouts, replicated across multiple itch modalities\",\n      \"pmids\": [\"25209280\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"GRPR mediates GRP-induced neutrophil chemotaxis; GRP-induced neutrophil migration in vitro is dependent on PLC-β2, PI3K, ERK, and p38 signaling, and is independent of Gαi protein. In vivo, GRP-induced peritoneal neutrophil recruitment is blocked by the GRPR antagonist RC-3095 and requires macrophages and TNF.\",\n      \"method\": \"In vivo peritoneal neutrophil recruitment assay, in vitro chemotaxis assay with pharmacological inhibitors, macrophage depletion, TNF neutralization\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple pharmacological inhibitors defining signaling pathway, in vivo and in vitro, genetic/pharmacologic blockade of GRPR\",\n      \"pmids\": [\"22203955\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"GRPR signals through the PI3Kγ/Akt pathway in spinal cord neurons; GRP directly activates small-size capsaicin-sensitive DRG neurons causing Ca2+ transients and membrane depolarization (~20 mV), and GRPR activation induces Akt phosphorylation in ex vivo spinal cords and in GRPR-transfected HEK293 cells. PI3Kγ inhibition reduces GRP-induced scratching.\",\n      \"method\": \"Electrophysiology (patch clamp), calcium imaging, Akt phosphorylation assay in ex vivo spinal cord and transfected HEK293 cells, intrathecal pharmacology, behavioral assays\",\n      \"journal\": \"The Journal of neuroscience\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — reconstitution in transfected cells, ex vivo electrophysiology, multiple orthogonal methods, behavioral validation\",\n      \"pmids\": [\"26658875\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"Spinal GRPR+ neurons (excitatory interneurons) receive direct and indirect inputs from C and Aδ fibers and form contacts with NK1R-expressing projection neurons. Noxious or cooling agents inhibit GRPR neuron activity via GABAergic signaling; capsaicin enhances both excitatory and inhibitory spontaneous synaptic transmission onto GRPR neurons.\",\n      \"method\": \"Electrophysiology, immunohistochemistry, pharmacological manipulation (GABAergic), behavioral assays\",\n      \"journal\": \"Scientific reports\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — electrophysiology with pharmacological dissection and circuit mapping, multiple methods\",\n      \"pmids\": [\"31676846\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"Spinal galanin+ GABAergic neurons form inhibitory synapses with GRPR+ neurons and gate GRPR+-dependent itch signaling; spinal nNOS+ neurons also provide local inhibitory input to GRPR+ neurons; GRPR+ neurons additionally receive long-range inhibitory input from the rostral ventromedial medulla.\",\n      \"method\": \"Viral tracing, electrophysiology, immunohistochemistry, circuit dissection\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — viral circuit tracing combined with electrophysiology and functional behavioral validation\",\n      \"pmids\": [\"31806757\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"Key amino acids in GRPR responsible for high-affinity GRP binding were identified; residues K101, Q121, A198, P199, S293, R288, and T297 are critical for GRP selectivity. Single and combined mutations in these residues reduce GRP affinity, and reverse mutations in BRS-3 confer GRP affinity gain.\",\n      \"method\": \"Site-directed mutagenesis, radioligand binding assays, chimeric receptor analysis, molecular modeling\",\n      \"journal\": \"Biochemical pharmacology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — mutagenesis with binding assays and reverse-mutation confirmation, multiple mutations tested\",\n      \"pmids\": [\"15670577\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"GRP acts via postsynaptic BB2 (GRPR) receptors in rat paraventricular thalamic neurons to suppress a Ba2+-sensitive inward rectifier K+ conductance and activate a non-selective cation conductance with TRPV1-like biophysical and pharmacological properties, producing sustained membrane depolarization and burst/tonic firing.\",\n      \"method\": \"Perforated patch clamp electrophysiology in acute brain slices, pharmacological dissection with TRPV1 antagonists and BB2 antagonists\",\n      \"journal\": \"The Journal of physiology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — direct electrophysiological recording with pharmacological dissection in acute slices, multiple ionic conductances identified\",\n      \"pmids\": [\"23359674\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"Brain GRPR (BB2 receptor)-mediated activation of sympatho-adrenomedullary outflow (plasma catecholamine release) in rats involves the PLC/diacylglycerol lipase signaling pathway rather than PLA2; GRP and bombesin (but not neuromedin B) elevate plasma catecholamines via BB2 receptors, and this is blocked by PLC and diacylglycerol lipase inhibitors.\",\n      \"method\": \"Intracerebroventricular injection, pharmacological inhibition of PLC/diacylglycerol lipase vs PLA2, plasma catecholamine measurement, receptor-subtype-selective antagonists\",\n      \"journal\": \"European journal of pharmacology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — pharmacological dissection of signaling pathway in vivo with receptor-selective antagonists, single lab\",\n      \"pmids\": [\"15910801\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"GRPR activation by bombesin (BBN) in prostate cancer cells promotes epithelial-to-mesenchymal transition (EMT), upregulating TWIST, SNAIL, and SLUG mRNA while downregulating E-cadherin and β-catenin. GRPR activation also increases tumor cell proliferation, migration in vitro, and tumor growth and invasion in vivo; blockade of GRPR upregulates E-cadherin and downregulates VIMENTIN and SNAIL.\",\n      \"method\": \"Stable GRPr transfection in Ace-1 cells, proliferation assay, migration assay, bioluminescence tumor growth imaging, qRT-PCR for EMT markers, in vivo xenograft\",\n      \"journal\": \"The Prostate\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — defined cellular phenotype with gain-of-function and loss-of-function, multiple readouts, in vitro and in vivo\",\n      \"pmids\": [\"26939805\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"GRP/GRPR signaling enhances alcohol-associated liver injury through two distinct mechanisms: IRF1-mediated Caspase-1 inflammasome activation and NOX2-dependent reactive oxygen species production. GRPR interacts with TLR4 to activate STAT1, which binds promoters of MLKL and CCL2 to induce TEC necroptosis, necroinflammation, and macrophage recruitment in acute kidney injury; STAT1 also induces GRP synthesis forming a positive feedback loop.\",\n      \"method\": \"Grpr knockout mice (global and conditional), GRPR overexpression, ChIP (STAT1 binding), co-immunoprecipitation (GRPR-TLR4 interaction), STAT1 overexpression rescue, pharmacological antagonist (RH-1402)\",\n      \"journal\": \"Hepatology / Molecular therapy\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — genetic knockout, conditional KO in tubular cells, mechanistic rescue with STAT1 overexpression, Co-IP for protein interaction, and pharmacological validation\",\n      \"pmids\": [\"37409771\", \"37415332\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"GRPR and NPRA (natriuretic peptide receptor A) signaling activate ERK1/2 in spinal neurons as a critical downstream pathway for itch transmission; phosphorylated ERK is detected in interneurons expressing GRPR, NPRA, NMBR, and sst2A. Blocking GRPR by genetic approaches or toxins significantly attenuates spinal ERK phosphorylation.\",\n      \"method\": \"RNA sequencing, western blot for phospho-ERK, pharmacological/genetic GRPR blockade, HEK293T transfection with receptor agonist stimulation, chronic itch mouse models\",\n      \"journal\": \"The Journal of investigative dermatology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — genetic and pharmacological GRPR blockade with ERK phosphorylation readout, supported by cell-based reconstitution\",\n      \"pmids\": [\"33039402\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"GRP-R-deficient male mice display increased non-aggressive social responses and altered olfactory preference (preferring conspecific odors over their own), establishing a role for GRPR in modulating social investigatory behavior and conspecific odor cognition.\",\n      \"method\": \"Germline knockout mice, social interaction behavioral tests, olfactory preference tests, pharmacological (diazepam) controls\",\n      \"journal\": \"Brain research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — clean KO with defined behavioral phenotype, multiple behavioral paradigms, single lab\",\n      \"pmids\": [\"10869497\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"GRP-R immunoreactivity localizes to the plasma membrane of tumor cells, and receptor immunostaining undergoes translocation after bombesin (BN) exposure, confirming receptor internalization upon agonist binding.\",\n      \"method\": \"Antipeptide antibody development, Western blot, immunohistochemistry, transfected cell surface staining, ligand-induced internalization/translocation assay\",\n      \"journal\": \"Virchows Archiv\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 — antibody-based localization with internalization validation in transfected cells, single lab\",\n      \"pmids\": [\"16967266\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"GRP/GRPR promotes hyperuricemia-induced tubular injury by suppressing ABCG2/PDZK1 and increasing TGF-β/Smad3 via NF-κB pathway activation; GRPR knockout or conditional knockout in renal tubular epithelial cells protects against hyperuricemia-induced renal fibrosis and inflammation.\",\n      \"method\": \"GRPR knockout and conditional KO mice, RNA-seq, NF-κB inhibitor, GRPR overexpression in HK2 cells, GRPR antagonist RH-1402 treatment in vivo\",\n      \"journal\": \"Biochemical pharmacology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — genetic KO with mechanistic pathway identification by RNA-seq and pharmacological inhibition, single lab\",\n      \"pmids\": [\"38084678\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"Spinal microglia activate the NLRP3/caspase-1/IL-1β axis under chronic itch conditions, and IL-1β signals through IL-1R1 expressed on GRPR+ neurons to enhance their activation, establishing a microglia-GRPR+ neuron interaction axis in chronic itch.\",\n      \"method\": \"NLRP3/caspase-1 pharmacological blockade, Grpr-eGFP and Grpr KO mice, intrathecal IL-1β and IL-1R1 antagonist injection, RNAscope ISH, immunohistochemistry\",\n      \"journal\": \"Allergy\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — genetic Grpr KO, pharmacological manipulation, and receptor-specific interventions with behavioral readout, single lab\",\n      \"pmids\": [\"36876522\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"GRPR+ neurons in the superficial dorsal horn are glutamatergic vertical cells concentrated in lamina I and outer lamina II; they receive monosynaptic input from Trpv1-expressing nociceptive afferents, respond to both noxious and pruritic stimuli, and their axons target projection neuron-containing regions. Chemogenetic activation produces both pain-related and itch-related behaviors.\",\n      \"method\": \"GRPR CreERT2 mouse line, viral tracing, immunohistochemistry, electrophysiology, DREADD-based chemogenetics, behavioral assays\",\n      \"journal\": \"Pain\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — genetic cell-type identification, circuit tracing, electrophysiology, and chemogenetic functional validation with multiple behavioral readouts\",\n      \"pmids\": [\"35543635\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1995,\n      \"finding\": \"GRPR was mapped to the Xp22.1-p22.2 region of the human X chromosome, localized between DXS43 and CALB3, establishing its chromosomal position.\",\n      \"method\": \"YAC contig construction, STS mapping, restriction mapping\",\n      \"journal\": \"Genomics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — direct physical mapping by YAC contig with multiple STSs, replicated by comparative mouse mapping\",\n      \"pmids\": [\"7759104\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"GRPR is a G protein-coupled receptor that, upon binding GRP, activates downstream signaling through PLC/IP3, PI3Kγ/Akt, and MAPK/ERK pathways to regulate itch transmission in spinal GRPR+ glutamatergic interneurons, neutrophil chemotaxis, cancer cell proliferation/EMT, and organ inflammation; it can heterodimerize with MOR1D to mediate opioid-induced itch via cross-activation, and with 5-HT1A to potentiate itch signaling, while its neuronal activity is gated by local GABAergic and long-range inhibitory inputs, and its ligand-binding specificity is determined by key extracellular/transmembrane residues including K101, Q121, A198, P199, S293, R288, and T297.\"\n}\n```","stage2_raw":"```json\n{\n  \"mechanistic_narrative\": \"GRPR is a G protein-coupled receptor for gastrin-releasing peptide (GRP) that functions as a central integrator of itch signaling in spinal cord circuits, a mediator of neutrophil chemotaxis, and a driver of cancer cell proliferation and organ inflammation. Ligand binding activates PLC/IP3, PI3Kγ/Akt, ERK/MAPK, and NF-κB signaling cascades, and high-affinity GRP recognition depends on extracellular/transmembrane residues K101, Q121, A198, P199, S293, R288, and T297 [PMID:15670577, PMID:26658875, PMID:22203955]. In the spinal dorsal horn, GRPR marks glutamatergic vertical interneurons in laminae I–II that receive nociceptive primary afferent input and are gated by local GABAergic (galanin+, nNOS+) and descending inhibitory neurons; GRPR heterodimerizes with MOR1D to mediate opioid-induced itch and with 5-HT1A to potentiate serotonergic itch facilitation [PMID:22000021, PMID:25453842, PMID:35543635, PMID:31676846, PMID:31806757]. Beyond itch, GRPR-TLR4 interaction activates STAT1 to drive necroptosis and inflammation in kidney injury, GRPR promotes epithelial-to-mesenchymal transition via TWIST/SNAIL/SLUG upregulation in prostate cancer, and GRPR signals through IRF1/Caspase-1 and NOX2 pathways to exacerbate alcohol-associated liver injury [PMID:37409771, PMID:37415332, PMID:26939805, PMID:38084678].\",\n  \"teleology\": [\n    {\n      \"year\": 1995,\n      \"claim\": \"Establishing the chromosomal locus of GRPR at Xp22.1-p22.2 provided the foundation for genetic studies of this receptor in humans.\",\n      \"evidence\": \"YAC contig construction and STS mapping on human X chromosome\",\n      \"pmids\": [\"7759104\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No functional consequence of X-linkage explored\", \"No disease-associated variants identified at this locus\"]\n    },\n    {\n      \"year\": 2000,\n      \"claim\": \"Germline Grpr knockout revealed a behavioral role in social interaction and olfactory processing, demonstrating CNS functions beyond gut/cancer biology.\",\n      \"evidence\": \"Grpr KO mice tested in social interaction and olfactory preference paradigms\",\n      \"pmids\": [\"10869497\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Circuit basis for social behavior phenotype unknown\", \"Not replicated independently\", \"Contribution of compensatory NMBR signaling not assessed\"]\n    },\n    {\n      \"year\": 2004,\n      \"claim\": \"Identification of key ligand-binding residues (K101, Q121, A198, P199, S293, R288, T297) defined the structural determinants of GRP selectivity over related bombesin receptors.\",\n      \"evidence\": \"Site-directed mutagenesis with radioligand binding and reverse mutations in BRS-3\",\n      \"pmids\": [\"15670577\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"No crystal or cryo-EM structure available\", \"Mechanism by which individual residues contribute to selectivity not resolved at atomic level\"]\n    },\n    {\n      \"year\": 2005,\n      \"claim\": \"Demonstration that brain GRPR signals through PLC/diacylglycerol lipase (not PLA2) to drive sympatho-adrenomedullary catecholamine release established tissue-specific signaling pathway utilization.\",\n      \"evidence\": \"Intracerebroventricular GRP injection with PLC and diacylglycerol lipase inhibitors, plasma catecholamine measurement\",\n      \"pmids\": [\"15910801\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Single lab pharmacological study\", \"Cell type mediating central catecholamine response not identified\"]\n    },\n    {\n      \"year\": 2011,\n      \"claim\": \"Discovery that MOR1D heterodimerizes with GRPR and that morphine triggers co-internalization with unidirectional cross-activation through PLCβ3/IP3R3 established the molecular mechanism of opioid-induced itch.\",\n      \"evidence\": \"Co-immunoprecipitation, internalization assays, PLCβ3/IP3R3 KO mice, behavioral assays\",\n      \"pmids\": [\"22000021\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Structural basis of MOR1D-GRPR heterodimer unknown\", \"Relevance to human opioid-induced pruritus not directly tested\"]\n    },\n    {\n      \"year\": 2011,\n      \"claim\": \"GRPR was shown to mediate GRP-induced neutrophil chemotaxis via PLC-β2, PI3K, ERK, and p38 in a Gαi-independent manner, extending GRPR function to innate immune cell recruitment.\",\n      \"evidence\": \"In vitro chemotaxis with pharmacological inhibitors and in vivo peritoneal neutrophil recruitment blocked by GRPR antagonist RC-3095\",\n      \"pmids\": [\"22203955\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct G protein coupling in neutrophils not characterized\", \"Role in human neutrophil chemotaxis not confirmed\"]\n    },\n    {\n      \"year\": 2013,\n      \"claim\": \"Electrophysiological dissection in paraventricular thalamic neurons revealed that GRPR activation suppresses an inward rectifier K+ conductance and activates a TRPV1-like non-selective cation conductance, defining the ionic basis of GRP-mediated excitation.\",\n      \"evidence\": \"Perforated patch clamp in acute brain slices with TRPV1 and BB2 antagonists\",\n      \"pmids\": [\"23359674\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether the same ionic mechanisms operate in spinal GRPR+ neurons is untested\", \"Identity of the TRPV1-like channel not molecularly confirmed\"]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"Three studies collectively defined the circuit logic of spinal itch: 5-HT1A-GRPR heteromers potentiate itch signaling, GRPR and NMBR cross-compensate for histaminergic itch, and BNP-NPRA signaling operates independently of the GRP-GRPR pathway.\",\n      \"evidence\": \"FRET/calcium imaging for 5-HT1A-GRPR interaction; double KO mice for GRPR-NMBR epistasis; pharmacological/genetic blockade for BNP independence\",\n      \"pmids\": [\"25453842\", \"25209280\", \"24438367\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether 5-HT1A-GRPR heteromerization occurs in human spinal cord is unknown\", \"How GRPR and NMBR cross-inhibit each other biochemically is unresolved\"]\n    },\n    {\n      \"year\": 2015,\n      \"claim\": \"Identification of PI3Kγ/Akt as a GRPR effector pathway in spinal neurons and DRG neurons expanded the signaling repertoire beyond PLC, showing that GRP directly depolarizes small DRG neurons and induces Akt phosphorylation.\",\n      \"evidence\": \"Patch clamp, calcium imaging, Akt phosphorylation in ex vivo spinal cord and GRPR-transfected HEK293 cells, PI3Kγ inhibitor reduces scratching\",\n      \"pmids\": [\"26658875\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether PI3Kγ acts in parallel or downstream of PLCβ not resolved\", \"DRG GRPR role in itch versus pain not fully dissected\"]\n    },\n    {\n      \"year\": 2016,\n      \"claim\": \"GRPR activation was shown to drive epithelial-to-mesenchymal transition in prostate cancer cells by upregulating TWIST, SNAIL, and SLUG while downregulating E-cadherin, linking receptor signaling to cancer invasion.\",\n      \"evidence\": \"Stable GRPR transfection in Ace-1 cells, qRT-PCR for EMT markers, in vivo xenograft tumor growth\",\n      \"pmids\": [\"26939805\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Downstream signaling pathway mediating EMT not identified\", \"Relevance to clinical prostate cancer progression not validated\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Circuit mapping established that spinal GRPR+ neurons receive C/Aδ fiber input, contact NK1R+ projection neurons, and are gated by local galanin+ GABAergic, nNOS+ inhibitory, and descending RVM inhibitory neurons, defining the inhibitory control architecture of itch transmission.\",\n      \"evidence\": \"Electrophysiology, viral tracing, immunohistochemistry, GABAergic pharmacology in spinal cord\",\n      \"pmids\": [\"31676846\", \"31806757\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Identity of descending RVM cell types projecting to GRPR+ neurons not fully resolved\", \"Whether GRPR+ neuron gating differs in chronic itch states is unknown\"]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"Genetic cell-type identification confirmed GRPR+ neurons as glutamatergic vertical cells in laminae I–outer II that respond to both noxious and pruritic stimuli and whose chemogenetic activation evokes pain and itch behaviors, resolving their modality tuning.\",\n      \"evidence\": \"GRPR-CreERT2 mice, viral tracing, electrophysiology, DREADD chemogenetics, behavioral assays\",\n      \"pmids\": [\"35543635\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"How GRPR+ neurons differentially encode itch versus pain at the population level is unresolved\", \"Contribution of non-GRP ligands to GRPR+ neuron activation in vivo unknown\"]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"GRPR was linked to organ inflammation and injury through three distinct mechanisms: GRPR-TLR4/STAT1-mediated necroptosis in kidney tubular cells, IRF1/Caspase-1 and NOX2-dependent pathways in alcohol-associated liver injury, and NF-κB-driven renal fibrosis in hyperuricemia, with STAT1 establishing a positive feedback loop by inducing GRP synthesis.\",\n      \"evidence\": \"Global and conditional Grpr KO mice, Co-IP for GRPR-TLR4, ChIP for STAT1, GRPR overexpression rescue, pharmacological antagonist RH-1402, RNA-seq\",\n      \"pmids\": [\"37409771\", \"37415332\", \"38084678\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether GRPR-TLR4 interaction is direct or scaffolded not resolved\", \"Human relevance of renal and hepatic GRPR pathology requires clinical validation\", \"Specificity of STAT1 feedback loop to GRPR versus other bombesin receptors untested\"]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"Microglial NLRP3/caspase-1/IL-1β signaling was shown to enhance GRPR+ neuron activation via IL-1R1 in chronic itch, revealing a neuroimmune amplification loop.\",\n      \"evidence\": \"NLRP3/caspase-1 inhibitors, Grpr-eGFP and Grpr KO mice, intrathecal IL-1β and IL-1R1 antagonist, RNAscope ISH\",\n      \"pmids\": [\"36876522\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Whether IL-1β directly modulates GRPR expression or signaling efficiency unknown\", \"Single lab study, not independently replicated\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"A high-resolution structure of GRPR bound to GRP or antagonist is lacking, and the mechanisms by which GRPR+ spinal neurons differentially encode itch versus pain at the population level remain unresolved.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"No cryo-EM or crystal structure of GRPR\", \"Population coding logic of GRPR+ neurons for itch versus pain undefined\", \"Therapeutic targeting of GRPR in chronic itch or organ inflammation lacks clinical trial data\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0060089\", \"supporting_discovery_ids\": [0, 1, 4, 5, 9]},\n      {\"term_id\": \"GO:0098772\", \"supporting_discovery_ids\": [3, 12]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005886\", \"supporting_discovery_ids\": [8, 15]},\n      {\"term_id\": \"GO:0005829\", \"supporting_discovery_ids\": [5]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"GO:0162582\", \"supporting_discovery_ids\": [0, 1, 4, 5, 9, 10, 12, 13]},\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [0, 1, 4, 5, 9, 10, 12, 13]},\n      {\"term_id\": \"R-HSA-168256\", \"supporting_discovery_ids\": [4, 12, 17]},\n      {\"term_id\": \"R-HSA-112316\", \"supporting_discovery_ids\": [6, 7, 18]},\n      {\"term_id\": \"R-HSA-5357801\", \"supporting_discovery_ids\": [12]},\n      {\"term_id\": \"R-HSA-1643685\", \"supporting_discovery_ids\": [11, 16]}\n    ],\n    \"complexes\": [],\n    \"partners\": [\n      \"OPRM1\",\n      \"HTR1A\",\n      \"NMBR\",\n      \"TLR4\",\n      \"PLCB3\",\n      \"ITPR3\",\n      \"PIK3CG\"\n    ],\n    \"other_free_text\": []\n  }\n}\n```"}